TradingNomadic

#Blue (Bluebird Bio) Gene therapeutics

Long
NASDAQ:BLUE   bluebird bio, Inc.
#BLUE is a candidate I've been watching for weeks.

Bluebird bio is bio tech company that develops therapeutics for genetic diseases and cancer treatment.

I posted this one originally on the 19th. My personal target will be 113.47 but we could ultimately see $137-163 beyond that in time. First target id expect to see is 72.37 if it ends up playing out.

The bullish gartley is the same harmonic i used to call #AMC a couple weeks back when it was under $3.00. This formation is one of the most powerful reversal patterns in trading and can be signs of an incoming gamma squeeze. I do believe this is the case here.

#BLUE reached $235 back in 2018, and id assume was shorted all the way down to 86, and initially as shorts exited, rose once again to 162 where (presumably) it was shorted into the ground once again.

When these shorts are once again exited and this formation is complete, you will see the power behind bullish harmonics and a short squeeze YEARS in the making.

Nothing is guaranteed in this market, and the S&P dropping won't help, but Im slowly adding to a position. This way if the price falls, I can average my way down until it reverses. This is generally my strategy with any asset.

This is in no way advice, and I could be wrong (I know, it's hard to believe) but its one to keep an eye on, and one im taking a chance on personally.
Comment:
Not pictured accidently, but there is also Bullish divergence on the 1W on both the RSI and the MACD.

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.